The North America IV hydration therapy market size was estimated at USD 1.6 billion in 2024 and is anticipated to grow at a CAGR of 8.7% from 2025 to 2030. The market is primarily driven by heightened consumer emphasis on proactive health management, the shift toward preventive wellness, and increasing demand for convenient, on-demand healthcare services. Post-pandemic health consciousness has significantly accelerated the adoption of intravenous (IV) hydration as a lifestyle and recovery solution. In parallel, the growing incidence of fatigue, migraines, and nutrient deficiencies has expanded the therapeutic scope of IV therapy beyond traditional clinical use.
The North America intravenous hydration therapy industry is rising, owing to increasing prevalence of chronic diseases such as cancer and diabetes. According to the CDC estimates, 6 in 10 adults in the U.S. are dealing with these health issues, creating a strong demand for effective healthcare solutions. IV hydration therapy is a crucial player, offering a direct and quick way to address consequences and management of chronic diseases. It becomes a valuable tool in improving the well-being of individuals facing these conditions. As chronic diseases become more common, the market is stepping up to provide specialized care and support for those who need it.
The prevalence of foodborne illnesses in the North American region poses significant health challenges. According to CDC estimates, 1 in 6 Americans falls ill from contaminated food or beverages each year, resulting in 3,000 deaths. The financial toll, as estimated by the U.S. Department of Agriculture (USDA), surpasses USD 15.6 billion annually. Within this landscape, the market is crucial in addressing the aftermath of foodborne illnesses. Intravenous hydration therapy is a supportive measure in managing dehydration, a common consequence of such illnesses. Offering efficient and rapid fluid replenishment, IV hydration therapy becomes a valuable component of healthcare response to mitigate the impact of foodborne illnesses on individuals' well-being.
Increasing awareness of the benefits of IV hydration therapies among North America’s population is boosting the market growth. According to the National Institute of Health and Care Excellence, numerous adult patients require Intravenous (IV) fluid therapy to address to fluid and electrolyte balance. IV therapy serves as a therapeutic intervention, administering fluids directly into the bloodstream to restore hydration and revitalize the body. Remarkably, IV hydration offers a faster and more complete absorption of vitamins, electrolytes, and antioxidants than oral intake, as it avoids the digestive system.
Innovation in the North America IV hydration therapy market is moderate, primarily emerging from enhancements in service accessibility, customization, and user interface rather than formulation breakthroughs. Providers are refining booking platforms, offering tailored infusion blends, and bundling services with complementary wellness offerings to differentiate in a crowded market. The focus remains on experience-driven care rather than disruptive medical innovation.
Mergers and acquisitions in the North America IV hydration therapy industry reflect a moderate level of activity, focused on strategic geographic expansion and operational synergies. Companies are consolidating regional operators to increase market coverage, reduce fragmentation, and streamline logistics in response to rising consumer demand for on-demand wellness services. These transactions often target high-traffic metropolitan areas or tourist-driven economies.
Regulatory influence is high in this market, shaped by state- and province-specific requirements governing medical procedures, clinician supervision, and telehealth integration. These rules can vary considerably, affecting scalability and compliance costs. Inconsistencies between jurisdictions pose operational friction for regional and national players.
The availability of substitutes presents a moderate challenge to the IV hydration therapy market. Alternatives such as oral supplements, over-the-counter wellness boosters, and in-clinic treatments offer similar benefits at lower cost or with fewer regulatory hurdles. However, they often fall short in terms of speed and perceived effectiveness, especially for acute symptom relief. The convenience and immediacy of mobile IV therapy continue to appeal to niche segments seeking performance recovery or aesthetic rejuvenation.
Regional expansion is high across North America, driven by increasing consumer interest in personalized health services and the convenience of home-based care. Urban markets are especially receptive, with demographic factors such as disposable income, lifestyle focus, and health engagement contributing to demand. Suburban and vacation-oriented markets are also emerging as secondary growth zones.
Based on type, the energy boosters segment accounted for the largest revenue share of 25.3% in 2024. Energy IV drip packets provide energy by infusing the body with a specifically prepared blend of electrolytes, vitamins, fluids, and antioxidants to battle sensations of exhaustion & low energy. There is a high adoption of energy supplements and drinks in the region, so demand for energy-boosting hydration therapy is increasing. For instance, according to the National Institute of Health, in the U.S., energy drinks are the most popular dietary drinks consumed by young adults & teens. Energy boost drips tend to increase energy levels, improve circulation & digestive issues, boost metabolism, and provide quick hydration. Energy IV hydration therapy is majorly adopted by athletes who require high energy due to high physical activity. IV therapy for sports was developed in response to the requirement for athletes to recover quickly.
Immune boosters segment anticipated to witness the significant market growth over the forecast period. Immune boost IV therapy is accepted as a safe and effective therapeutic option when delivered by a medical practitioner. Even though substantial scientific data do not support using vitamin IV drips, it produce good outcomes in restoring well-being and vitality. According to the CDC, about 6.2% of adults aged 18 to 64 in the U.S. have reduced immune function, as do approximately 2.6% of children. Immunosuppression seems to be growing as patients live longer with cancer, HIV, organ transplants, or chronic therapies, which leaves them more susceptible to infections. This further leads to increased demand for immune boosters among the population which boosts the market.
Based on gender, the woman segment accounted for the largest revenue share of 52.7% in 2024, owing to the increasing adoption of IV therapies in skincare & beautification and for overall wellness by women. Skin rejuvenation treatment is any method or procedure of changing the appearance of skin. Skin rejuvenation treatments are most successful when delivered by IV therapy, as greater absorption enhances the treatment's effects. The treatment is widely adopted by women aged 24 to 54 years when signs of aging are predominantly observed. IV hydration therapy is a promising treatment for overall skin wellness by reducing wrinkles & spots and providing an improved skin appearance, making it highly suitable for any skin type. Moreover, there is an increase in the number of medical spas offering these treatments for women, which makes the treatment available to a large population, further increasing the adoption is significantly boosting the market progress.
Men segment is anticipated to witness a significant market growth over the forecast period, owing to increasing adoption of IV therapies for boosting immunity, energy, and metabolism. Over the years, it has been observed that the percentage of male athletes is increasing over the female athletes, which makes the use of intravenous hydration therapy for energy boosting more prominent in men compared to women. Moreover, men tend to have a weaker immune system than women. It was observed that even if the infection is similar in both genders, males tend to suffer more severe infections than females. During the pandemic, the adoption of IV hydration therapy was seen to be higher in males than in females, owing to the severity of the infection.
Based on end-use, the hospitals & clinics segment accounted for the largest revenue share of 41.5% in 2024. This is attributed to the fact that most infusion therapies are carried out in hospitals and cosmetic centers/ clinics for treatment of a wide variety of conditions. The rising need for hospitalization among the population due to an increase in the number of people suffering from chronic disorders is another factor propelling market growth. On average, hospitalization lasts 4 to 5 days, which impels the need to supply patients with medications and nutrients through IV routes. Moreover, these services are offered in hospitals at a lower cost under a licensed physician's supervision, making it a prime location for IV hydration therapy.
The home healthcare segment is estimated to register the fastest CAGR over the forecast period. The segment's growth is due to the increasing geriatric population prone to various disorders. IV hydration therapy at home is a method of receiving IV treatment prescribed by a doctor without traveling to a hospital or clinic. This setting offers a safe and efficient alternative to hospitalization. The adoption of home healthcare services is increasing owing to the ease and comfort of obtaining treatments at home. These aspects are boosting the market growth.
Based on age, the 18-60 segment accounted for the largest revenue share of 53.2% in 2024. The segment's dominance is due to this age group's increasing adoption of IV hydration therapy for various conditions. For instance, hydration therapy for skincare and rejuvenation is majorly adopted by females in this age group, as a major change in skin appearance and texture is witnessed during this stage of an individual’s life. Most athletes and sports personnel who require energy boosters regularly fall under this age group, further increasing the adoption of hydration therapies in these individuals.
The 60+ segment is anticipated to witness significant market growth over the forecast period, owing to an increasing prevalence of major disorders in the geriatric population. Minor cognitive disorders are thought to affect between 2% and 10% of 65-year-olds and up to 25% of 85-year-olds. The prevalence of major cognitive disorders is difficult to estimate, but they are estimated to affect between 2% and 10% of 65-year-olds and up to 25% of 85-year-olds. IV hydration therapy to boost memory and enhance brain health is widely adopted in individuals above the age of 60 years. IV hydration therapy serves as one of the most efficient methods of delivering critical fluids into the body. It avoids the digestive system, which slows absorption, by using an IV drip to administer the chemicals directly to the bloodstream. These aspects are boosting the market growth.
The U.S. dominated the overall market with a revenue share of 86.8% in 2024. High share of the market in the region is attributed to the unprecedented adoption of IV hydration therapy in the U.S. There is an increasing demand for immune boosters and energy in the region owing to rising prevalence of chronic diseases. The region shows a high disposable income and patient spending on overall wellness, hence, increasing market demand. Moreover, key regional players are focusing on introducing new technologies to capitalize on rising demand for IV hydration therapies. For instance, in April 2023, The DRIP Bar Vitamin Therapy partnered with Kevin Harrington for IV therapy franchise as a major investor. The franchise has been gaining immense acceptance across the region.
Canada is expected to grow at a significant rate during the forecast period. Adoption of IV hydration therapy is limited in the country owing to a lack of awareness and low healthcare spending. IV hydration therapy is a minimally invasive treatment that allows fluids to be delivered directly into the bloodstream, which is considerably more effective and faster than absorbing fluids through the digestive tract. It is also adopted for various applications, including immunity boosting, energy boosting, hangover management, and overall wellness. However, due to the lack of awareness across Canada, the demand for IV hydration therapy is moderate.
Drip Hydration, DriPros IV Hydration Wellness, wHydrate, and Renew Ketamine & Wellness Center are some dominant players operating in the North America IV hydration therapy industry.
Drip Hydration is a mobile IV therapy company that provides IV treatments directly to patients. The company also offers in-home IV infusions with essential fluids, vitamins, electrolytes, and antioxidants.
DriPros offers mobile IV hydration and vitamin therapy to the Upstate SC region. Its services include drips tailored to help with hangovers, migraine headaches, athletic pre/post workouts, beauty/skin issues, and boosting immunity.
wHydrate offers IV therapy for an intravenous drip to administer vital minerals, electrolytes, vitamins, and amino acids. The company is considered to be the best in the South East network of IV therapy clinics and lounges.
Hydration Room, Hydrate IV, and AliveDrip are some of the emerging market players functioning in North America IV hydration therapy industry.
Hydration Room was established by board certified Anesthesiologist Dr. Brett Florie. Hydration Room integrates both allopathic and osteopathic medicine into customized vitamin injection and IV therapies.
AliveDrip is a mobile IV therapy company that offers comprehensive wellness, diagnostic, and IV vitamin infusion services. For IV vitamin infusions, the company provides more than 10 exclusive formulas.
In March 2025, purelyIV launched its Take-Home B12 Kit, designed to complement in-home IV hydration therapy and help clients maintain their B12 levels between sessions. The kit includes a 3-month supply of Vitamin B12 injections, syringes, alcohol pads, and a sharps container, with a free online consultation included to ensure proper usage.
In May 2024, XWELL, Inc. launched IV hydration drip therapy at its XpresSpa site in Miami International Airport (MIA), initiating a pilot program in collaboration with Revitalize IV Lounge. This new service provides four tailored hydration treatments aimed at enhancing energy, boosting immune health, and promoting recovery.
In June 2022, DRIPBaR has partnered with entrepreneur and investor Kevin Harrington, who is set to become a significant investor in the IV therapy franchise. The franchise is rapidly gaining widespread acceptance in the region.
In March 2022, PAVmed Inc., a versatile medical technology company, successfully implanted its PortIO Intraosseous Infusion System in three patients at the Clinica Porto Azul in Barranquilla, Colombia.
Report Attribute |
Details |
Market size value in 2025 |
USD 1.7 billion |
Revenue forecast in 2030 |
USD 2.6 billion |
Growth rate |
CAGR of 8.7% from 2025 to 2030 |
Base year for estimation |
2024 |
Historical data |
2018 - 2023 |
Forecast period |
2025 - 2030 |
Quantitative units |
Revenue in USD million/billion and CAGR from 2025 to 2030 |
Report coverage |
Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
Segments covered |
Type,age, gender, end-use, country |
Country scope |
U.S.; Canada; Mexico |
Key companies profiled |
Drip Hydration; DriPros IV Hydration Wellness; wHydrate; Renew Ketamine & Wellness Center; R2 Medical Clinic; AliveDrip; Hydrate IV; Hydration Room |
Customization scope |
Free report customization (equivalent up to 8 analyst’s working days) with purchase. Addition or alteration to country, regional, and segment scope. |
Pricing and purchase options |
Avail customized purchase options to meet your exact research needs. Explore purchase options |
This report forecasts revenue growth at regional & country levels and provides an analysis of the industry trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the North America IV hydration therapy market report based on type, age, gender, end-use, and country:
Type Outlook (Revenue, USD Million, 2018 - 2030)
Immune Boosters
Energy Boosters
Skin Care
Migraine
Others
Age Outlook (Revenue, USD Million, 2018 - 2030)
0-18
18-60
60+
Gender Outlook (Revenue, USD Million, 2018 - 2030)
Men
Women
End-use Outlook (Revenue, USD Million, 2018 - 2030)
Hospitals & Clinics
Wellness Centers & Spa
Home Healthcare
Others
Country Outlook (Revenue, USD Million, 2018 - 2030)
U.S.
Canada
Mexico
b. The North America IV hydration therapy market size was estimated at USD 1.15 billion in 2023 and is expected to reach USD 1.23 billion in 2024.
b. The North America IV hydration therapy market is expected to grow at a compound annual growth rate of 8.1% from 2024 to 2030 to reach USD 1.96 billion by 2030.
b. Energy Boosters segment accounted for the largest revenue share of 28.6% in 2023. Energy IV drip packets provide energy by infusing the body with a specifically prepared blend of electrolytes, vitamins, fluids, and antioxidants to battle sensations of exhaustion & low energy.
b. Some of the players are Drip Hydration, DriPros IV Hydration Wellness, wHydrate, Renew Ketamine & Wellness Center, R2 Medical Clinic, AliveDrip, Hydrate IV, Hydration Room
b. Rising foodborne illnesses in the region and increasing awareness of the benefits of IV hydration therapies are factors expected to drive market growth in the forecast period.
NEED A CUSTOM REPORT?
We offer custom report options, including stand-alone sections and country-level data. Special pricing is available for start-ups and universities.
Request CustomizationWe are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.
"The quality of research they have done for us has been excellent."